Download as docx, pdf, or txt
Download as docx, pdf, or txt
You are on page 1of 2

DRUG NAME MECHANISM OF INDICATION SIDE EFFECTS NURSING RESPONSIBILITIES

ACTION
GENERIC NAME: Inhibits HMG-CoA Primary prevention of Common:
 Atorvastatin reductase, the cardiovascular disease Atorvastatin is  Monitor for headache.
enzyme that in high-risk pts. generally well  Assess for rash, pruritus, malaise.
BRAND NAME: catalyzes the early Reduces risk of stroke tolerated. Side  Monitor cholesterol, tri- glyceride lab
Lipitor step in cholesterol and heart attack in pts effects are usually values for therapeutic response.
synthesis. with type 2 diabetes mild and transient.  Monitor hepatic function tests,
CLASSIFICATION: Therapeutic Effect: with or without 
 HMG CoA reductase Decreases LDL and evidence of heart Frequent (16%):
inhibitors VLDL, plasma disease. Headache.
triglyceride levels;
DOSAGE: increases HDL Occasional (5%–
40mg/tab 1 tab concentration. 2%): Myalgia, rash,
pruritus, allergy.

Rare (less than 2%–


1%):
Flatulence,
dyspepsia,
depression.
CONTRAINDICATION ADVERSE EFFECTS

Active hepatic disease, Potential for


lactation, pregnancy, cataracts,
unexplained elevated photosensitivity,
hepatic function test myalgia,
results rhabdomyolysis.

You might also like